Atlas Trials

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Clinical trial NCT02020707 · COMPLETED

Trial details

NCT number
NCT02020707
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous CarcinomaCervical CarcinosarcomaCervical Squamous Cell CarcinomaClinical Stage IV Cutaneous Melanoma AJCC v8Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous Adenocarcinoma
Start date
2014-02-24
Primary completion
2024-07-18
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.